Mebendazol Leidapharm

Mebendazole, the active ingredient in Mebendazol Leidapharm, is an anthelmintic (benzimidazole) presented as an oral tablet for systemic use. It is employed to treat intestinal helminth infections such as ascariasis, hookworm and trichuriasis in both children and adults. It is approved for use in the European Union market.

GNH USA supplies Mebendazol Leidapharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Mebendazole acts on intestinal nematode infections, eliminating the parasites responsible for these diseases.

- Ascariasis: eliminates Ascaris lumbricoides worms, relieving intestinal symptoms and preventing complications. - Hookworm infection: eradicates Ancylostoma duodenale and Necator americanus, reducing anemia and gastrointestinal distress. - Trichuriasis: removes Trichuris trichiura, improving bowel function and reducing inflammation.

Mebendazole may cause adverse reactions, which are generally mild but can include serious events in rare cases.

Common Side Effects: - Abdominal pain: mild discomfort in the stomach area. - Nausea: feeling of queasiness or urge to vomit. - Vomiting: expulsion of stomach contents. - Diarrhea: loose or watery stools. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Blood dyscrasias: neutropenia or agranulocytosis. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before prescribing Mebendazol Leidapharm, clinicians should consider several precautionary measures to ensure patient safety.

- Pregnancy: evaluate risk and benefit; use only if clearly needed. - Breastfeeding: assess potential exposure to infant; consider alternative therapy. - Liver disease: use with caution in patients with hepatic impairment. - Drug interactions: review concomitant medications for possible interactions. - Store at room temperature: keep in original packaging, protect from moisture and heat.

Mebendazole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Cimetidine: may increase plasma concentrations of mebendazole. - Griseofulvin: may reduce the antiparasitic effect of mebendazole. - Carbamazepine: may lower mebendazole levels, decreasing therapeutic effect.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin): may alter metabolism of mebendazole. - Warfarin: monitor INR as mebendazole may affect anticoagulation.